FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 354:1190-1193 March 16, 2006 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Papanikolaou, E. G. PubMed Citation

Worldwide, the use of assisted reproductive technology is increasing.^1,2,3 The technology, which includes such treatments for infertility as in vitro fertilization, accounts for 2 to 3 percent of births in many European countries¹ and approximately 1 percent of U.S. births overall, with higher proportions for states, such as Massachusetts, that mandate insurance coverage for the procedures.²

Enthusiasm for assisted reproductive technology, however, is tempered by concern about adverse sequelae among the children conceived with the use of these techniques, in particular those associated with multiple births. In the United States, because two or more embryos have been routinely transferred in . . . [Full Text of this Article]

Source Information

From the National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta.

This article has been cited by other articles:

• Meintjes, M., Chantilis, S. J., Ward, D. C., Douglas, J. D., Rodriguez, A. J., Guerami, A. R., Bookout, D. M., Barnett, B. D., Madden, J. D. (2009). A randomized controlled study of human serum albumin and serum substitute supplement as protein supplements for IVF culture and the effect on live birth rates. Hum Reprod 24: 782-789 [Abstract] [Full Text]  
• Stillman, R. J. (2007). A 47-Year-Old Woman With Fertility Problems Who Desires a Multiple Pregnancy. JAMA 297: 858-867 [Abstract] [Full Text]